N
Nancy M. P. King
Researcher at Wake Forest University
Publications - 126
Citations - 2791
Nancy M. P. King is an academic researcher from Wake Forest University. The author has contributed to research in topics: Informed consent & Therapeutic misconception. The author has an hindex of 26, co-authored 118 publications receiving 2568 citations. Previous affiliations of Nancy M. P. King include University of North Carolina at Chapel Hill & Vanderbilt University.
Papers
More filters
Journal ArticleDOI
Clinical Trials and Medical Care: Defining the Therapeutic Misconception
Gail E. Henderson,Larry R. Churchill,Arlene M. Davis,Michele M. Easter,Christine Grady,Steven Joffe,Nancy E. Kass,Nancy M. P. King,Charles W. Lidz,Franklin G. Miller,Daniel K. Nelson,Jeffrey Peppercorn,Barbra Bluestone Rothschild,Pamela Sankar,Benjamin S. Wilfond,Catherine Zimmer +15 more
TL;DR: A key component of informed consent to participate in medical research includes understanding that research is not the same as treatment.
Journal ArticleDOI
Defining and Describing Benefit Appropriately in Clinical Trials
TL;DR: Both low risks of great harm and high risks of small harm must be disclosed to prospective subjects and should be explained and categorized in ways that help potential subjects to understand and weigh them appropriately.
Journal ArticleDOI
Ethical issues in stem cell research and therapy.
Nancy M. P. King,Jacob Perrin +1 more
TL;DR: This review provides an overview of the most significant issues with which the stem cell research community should be familiar and draws on a sample of the bioethics and scientific literatures to address issues that are specific to stem cellResearch and therapy.
Journal ArticleDOI
Children as decision makers: guidelines for pediatricians
Nancy M. P. King,Alan W. Cross +1 more
TL;DR: Il s'agit ici d'un point de vue beaucoup plus large que la capacite legale du consentement, mais de the capacite de l'enfant a un consentement eclaire, de l'sevaluation and of l'encouragement of cette capacite.
Journal ArticleDOI
Therapeutic misconception in early phase gene transfer trials.
Gail E. Henderson,Michele M. Easter,Catherine Zimmer,Nancy M. P. King,Arlene M. Davis,Barbra Bluestone Rothschild,Larry R. Churchill,Benjamin S. Wilfond,Daniel K. Nelson +8 more
TL;DR: A multivariate model demonstrates the importance of both subject- and study-level factors as predictors of this TM index: education, disease type, and communication by study personnel about the likelihood of benefit.